beta-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression

Transplant Proc. 2001 May;33(3):2384-5. doi: 10.1016/s0041-1345(01)02031-0.

Authors

I Folkmane¹, S Chapenko, D Amerika, J Bicans, M Murovska, R Rosentals

Affiliation

¹ Department of Transplantation, Medical Academy of Latvia, Riga, Latvia.

PMID: 11377569
DOI: 10.1016/s0041-1345(01)02031-0

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adult
Azathioprine / therapeutic use
Cyclosporine / therapeutic use
Cytomegalovirus / isolation & purification
Cytomegalovirus Infections / diagnosis
Drug Therapy, Combination
Herpesviridae Infections / diagnosis
Herpesviridae Infections / physiopathology*
Herpesvirus 7, Human / growth & development*
Herpesvirus 7, Human / isolation & purification
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology*
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use*
Polymerase Chain Reaction
Postoperative Complications / virology
Prednisolone / therapeutic use
Recurrence
Virus Activation*

Substances

Immunosuppressive Agents
Cyclosporine
Prednisolone
Mycophenolic Acid
Azathioprine